The added value of left atrial strain in cancer‐therapy‐related cardiac dysfunction

EchocardiographyVolume 41, Issue 3 e15792 COMMENTARY The added value of left atrial strain in cancer-therapy-related cardiac dysfunction Laura-M Romero Acero MD, Laura-M Romero Acero MD Albert Einstein Coll of Medicine/Cardiac Care and Vascular Medicine, Bronx, New York, USASearch for more papers by this authorMichele Nanna MD, Corresponding Author Michele Nanna MD [email protected] orcid.org/0000-0002-9664-6046 Albert Einstein Coll of Medicine/Cardiac Care and Vascular Medicine, Bronx, New York, USA Correspondence Michele Nanna, MD, Albert Einstein College of Medicine/Cardiac Care and Vascular Medicine, 1461 Astor Ave, Bronx, NY 10469, USA. Email: [email protected]Search for more papers by this author Laura-M Romero Acero MD, Laura-M Romero Acero MD Albert Einstein Coll of Medicine/Cardiac Care and Vascular Medicine, Bronx, New York, USASearch for more papers by this authorMichele Nanna MD, Corresponding Author Michele Nanna MD [email protected] orcid.org/0000-0002-9664-6046 Albert Einstein Coll of Medicine/Cardiac Care and Vascular Medicine, Bronx, New York, USA Correspondence Michele Nanna, MD, Albert Einstein College of Medicine/Cardiac Care and Vascular Medicine, 1461 Astor Ave, Bronx, NY 10469, USA. Email: [email protected]Search for more papers by this author First published: 08 March 2024 https://doi.org/10.1111/echo.15792Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Graphical Abstract REFERENCES 1Cardinale D, Colombo A, Bacchiani G, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015; 131(22): 1981-1988. 10.1161/CIRCULATIONAHA.114.013777 CASPubMedWeb of Science®Google Scholar 2de Moor JS, Mariotto AB, Parry C, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev. 2013; 22(4): 561-570. 10.1158/1055-9965.EPI-12-1356 PubMedWeb of Science®Google Scholar 3Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016; 29(4): 277-314. 10.1016/j.echo.2016.01.011 PubMedWeb of Science®Google Scholar 4Galderisi M, Esposito R, Sorrentino R, et al. Atrial fibrillation, cancer and echocardiography. J Cardiovasc Echogr. 2020; 30(Suppl 1): S33-S37. 10.4103/jcecho.jcecho_8_19 PubMedGoogle Scholar 5Sarvari SI, Haugaa KH, Stokke TM, et al. Strain echocardiographic assessment of left atrial function predicts recurrence of atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2016; 17(6): 660-667. 10.1093/ehjci/jev185 PubMedWeb of Science®Google Scholar 6Park H, Kim KH, Kim HY, et al. Left atrial longitudinal strain as a predictor of Cancer therapeutics-related cardiac dysfunction in patients with breast cancer. Cardiovasc Ultrasound. 2020; 18(1): 28. 10.1186/s12947-020-00210-5 PubMedWeb of Science®Google Scholar 7Huynh QL, Kalam K, Iannaccone A, et al. Functional and anatomic responses of the left atrium to change in estimated left ventricular filling pressure. J Am Soc Echocardiogr. 2015; 28(12): 1428-1433. e1. 10.1016/j.echo.2015.07.028 PubMedWeb of Science®Google Scholar 8Donal E, Behagel A, Feneon D. Value of left atrial strain: a highly promising field of investigation. Eur Heart J Cardiovasc Imaging. 2015; 16(4): 356-357. 10.1093/ehjci/jeu230 PubMedWeb of Science®Google Scholar 9Lassen MC, Arya F, Biering-Sørensen T, et al. Left atrial strain is reduced following trastuzumab in breast cancer patients. Echocardiography. 2024; 41(1):e15751. 10.1111/echo.15751 PubMedWeb of Science®Google Scholar 10Laufer-Perl M, Arias O, Dorfman SS, et al. Left atrial strain changes in patients with breast cancer during anthracycline therapy. Int J Cardiol. 2021; 330: 238-244. 10.1016/j.ijcard.2021.02.013 PubMedWeb of Science®Google Scholar 11Tadic M, Genger M, Cuspidi C, et al. Phasic left atrial function in cancer patients before initiation of anti-cancer therapy. J Clin Med. 2019; 8(4): 421. 10.3390/jcm8040421 CASPubMedWeb of Science®Google Scholar 12Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2022; 79(17): e263-e421. 10.1016/j.jacc.2021.12.012 PubMedWeb of Science®Google Scholar 13Guarneri V, Lenihan DJ, Valero V, et al. Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience. J Clin Oncol. 2006; 24(25): 4107-4115. 10.1200/JCO.2005.04.9551 CASPubMedWeb of Science®Google Scholar 14Wang SY, Long JB, Hurria A, et al. Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival. Breast Cancer ResTreat. 2014; 146(2): 411-419. 10.1007/s10549-014-3029-0 Web of Science®Google Scholar 15Santos AB, Roca GQ, Claggett B, et al. Prognostic relevance of left atrial dysfunction in heart failure with preserved ejection fraction. Circ Heart Fail. 2016; 9(4):e002763. 10.1161/CIRCHEARTFAILURE.115.002763 CASPubMedWeb of Science®Google Scholar Volume41, Issue3March 2024e15792 ReferencesRelatedInformation